Stagliano Nancy
SEC insider (Form 3/4/5 filer). CIK 0001817449. Director at Electra Therapeutics, Inc. (ETRA). 1 reported Form 4/5 transaction since Sep 2024; latest on Sep 21, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Stagliano Nancy has filed insider reports for
- Electra Therapeutics, Inc. (ETRA): Director
Stagliano Nancy
CIK: 0001817449
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ETRA
Electra Therapeutics, Inc.
Director